Requisitioning a resolution at a GSK Annual General Meeting

Slides:



Advertisements
Similar presentations

Advertisements

MEETINGS Shumeet K. Grewal. The word ‘Meetings’ implies the coming together of a certain number of members for transacting the business in agenda, for.
Appointment & Qualifications of Director.  All Private and Public Limited Companies and One Person Companies (OPC)
© 2013 Grant Thornton UK LLP | Certification work report for North Hertfordshire District Council | December 2013 Certification report 2012/13 for North.
COMPANY MEETINGS.
Extraordinary General Shareholders’ Meeting Brussels, 13 April 2011.
MEETINGS OF SHARE HOLDERS. NEED FOR MEETING TO RATIFY TO EXPRESS THEIR DISAPPROVAL OF, THE DIRECTOR’S PAST CONDUCT. TO CONSIDER THEIR FUTURE PLANS. TO.
EXTRAORDINARY GENeRAL MEETINGS
CAn For the aspiring Chartered Accountants. COMPANIES ACT, 2013 Sections relevant to Board of Directors.
Applying for Citizenship in Ireland by naturalisation. Presentation by Brian Killoran Information and Referral Service Coordinator Immigrant Council of.
ENA Chapter Treasurer DUTIES AND RESPONSIBILITIES.
Corporate Secretary ship June 2008: Meeting
PROPOSED BY-LAW AMENDMENTS. Proposed By-Law Amendments 2015 May 13, 2015.
PREPARED FOR: PM ALICIA TAN PREPARED BY: NUR HUSNA RASHID.
Trevisan & Associates Law Firm SHAREHOLDERS’ MEETING The Meeting is called by the Board of Directors or by the Management Board The Notice indicates the.
Tier 4 Visa Maintenance Requirements
Calling and Holding AGMs Laws, Standards and Good Practice Kevin Prendergast, Head of Advocacy and Assessment, ODCE.
INCREASE OF AUTHORISED SHARE CAPITAL 1)Where a company planning to increase its share capital beyond its authorised share capital, it should file with.
1 Workshop on the Directive 96/61/EC concerning (IPPC) Integrated pollution prevention and control INFRA Public participation & access to environmental.
Annual General Meetings Planning for Success. What is the AGM for ? The required Annual General Meeting of your club. Open to all members. Public statement.
Governance Requirements and Structures Sport and the Law Conference Alastair Cotton, Daniella Lloyd 25 March 2013.
INDEX Check points Process before acceptance Process at the time of acceptance Process after acceptance.
SHAREHOLDER UPDATE – ROADSHOWS MARCH Objectives of Eyomhlaba 2.Highlights of Current holding as at 28 February Indicative net.
INDIAN TAKEOVERS Meaning Of Acqusition: When an “acquirer” takes over the control of the “target company”, it is termed as takeover. When an acquirer.
May 5, 2016 May 5, Reporting obligations for  Investment banks,  Stockbrokers and dealers  FM and Investment advisers 2. Publication financial.
An Overview on the Management of Meetings  CALVIN NYACHOTI.
Consumer.vic.gov.au Becoming an incorporated association.
Welcome! Local Cultural Council Online Application Training.
NJDOE Testing for Lead in School Drinking Water
Chapter 14 Members’ Meetings
ELIGIBILITY CRITERIA (with notes)
MANAGEMENT OF MEETINGS
Chapter 3 MANAGEMENT.
Presented by: Antony N. Gichia Regional Audit Center Mombasa
OFFICE OF THE CITY CLERK AUGUST 24, 2017 REQUEST FOR DIRECTION REGARDING POTENTIAL AMENDMENTS TO THE CITY CHARTER THAT MAY BE NECESSARY TO COMPLY WITH.
PROSPECTS – EDUCATIONAL CLINIC MALTA
AN OVERVIEW ON THE MANAGEMENT OF MEETINGS
ISSUES IN INDIAN COMMERCE
Chapter 16 Accounts and Reporting
Tender Evaluation and Award Process
Content of Tender Dossier - Instructions to Tenderers - Tenders
Meetings and resolutions
INSTITUTE OF CERTIFIED PUBLIC SECRETARIES OF KENYA
PROCEDURAL BASICS FOR THE MEETINGS OF MALAYSIAN PARLIAMENT
- Period before Tenders Submission –
Agenda 5.11 General Regulations
Meeting Procedure.
Annual general meeting
Corporations and Trusts Law Chapter 5 Management
Tender Offer Agent Processing Steps American Bar Association Mergers and Acquisitions Committee Meeting January 26 & 27, 2018.
COMPANIES ACT, 2013 ANNUAL RETURN (MGT 7)
Chapter Eight Members and Membership
BVI Business Companies Act Workshop
VAT in UAE Registration Criteria How to register for VAT
SANIRE Branches Guidelines
Transfer of shares to Investor Education and Protection Fund
PROPOSED CHANGES TO THE CLUB’S CONSTITUTION AND BYLAWS
Royal Mail Group: Publishing Volume Commitment Incentive.
CHALLENGES TO VOTER REGISTRATION APPLICATIONS AND REGISTERED VOTERS
Procedural review of initial WG ballot on P802.1CF
Kentucky County Treasurer’s Duties of a County Treasurer
Royal Mail Group: Testing and Innovation Incentive.
Meetings And Resolutions.
Royal Mail Group: Business Mail Testing and Innovation Incentive.
Requisitioning a resolution at a GSK Annual General Meeting
Royal Mail Group: Testing and Innovation Incentive.
ELIGIBILITY CRITERIA FOR FULL-TIME UNDERGRADUATE AND PGCE STUDENTS (with notes) Student Finance is available so that students can make the most of their.
BOOKS OF ACCOUNT & FINANCIAL STATEMENTS
Overnight/Out-of-town Travel Training
Requisitioning a resolution at a GSK Annual General Meeting
Presentation transcript:

Requisitioning a resolution at a GSK Annual General Meeting

Requisitioning a resolution There are occasions where shareholders may wish to draw important matters to the attention of other shareholders by proposing a resolution to be put to an Annual General Meeting (AGM). This presentation sets out that procedure.

Requisitioning a resolution Introduction The procedure for requisitioning a resolution is governed by English common law and statute This specifies that, unless a requisition is validly received before the end of the financial year preceding the meeting, a company’s costs in complying with a requisition are to be met by requisitionists The funds to cover such costs must be deposited with the company before a requisition can be actioned GSK has estimated that the cost of complying with a requisition may be as high as £200,000.

Requisitioning a resolution Introduction (cont.) At GSK’s AGM in May 2005 the Articles of Association were amended to remove the requirement for requisitionists to pay a deposit by authorising GSK to meet its own costs in complying with a valid requisition, provided that the requisition is received by 31 January each year Requisitionists who lodge a requisition after 31 January, but before the UK legal deadline of 6 weeks prior to the AGM, would, however, be required to pay a deposit and to meet GSK’s costs of complying with the requisition Requisitionists would, however, be free to include a supplementary resolution to request that GSK pays its own costs in complying with the requisition Shareholders wishing to requisition a resolution may find the following information helpful, but should in any event seek their own independent legal advice. A glossary of terms is set out at the end of this booklet.

Index Requisitioning a resolution Requirements 6 Eligibility 8 Procedure 10 Drafting and Submission 13 Supporting Statements 15 Costs 18 Supplementary Information Key dates for GSK’s 2018 AGM 21 Contacts 22 Glossary of Terms 23

Requisitioning a resolution Requirements: members To ensure there is no question of a member or indirect investor with a small shareholding requisitioning a resolution without sufficient support from other members or indirect investors, UK law sets out minimum shareholding requirements before a requisition can be made For a requisition involving only shareholders whose shares are registered directly in their own name (members), a requisition must be supported by the following in order to be valid, either: not less than 100 members holding shares on which there has been paid up an average sum per member of not less than £100; or members representing not less than 5% of the total voting rights of all the members.

Requisitioning a resolution Requirements: indirect investors For indirect investors whose shares are held via a nominee or for GSK American Depository Receipts (ADR) holders, a requisition must be supported by the following in order to be valid: not less than 100 persons holding shares directly or indirectly on which there has been paid up an average sum per person of not less than £100.

Requisitioning a resolution Eligibility: members Are you part of a group of 100 or more persons holding £10,000 in nominal value of GSK Ordinary Shares i.e. 40,000 GSK Ordinary Shares? If the answer is ‘Yes’ then you should be eligible to requisition a resolution, although certain procedural formalities may be required If the answer to the above question is ‘No’ then you and the persons with whom you intend to lodge the requisition might still be eligible to requisition a resolution, if together you hold at least 5% of the total shareholder voting rights in GSK Ordinary Shares i.e. approximately 247 million GSK Ordinary Shares If you fulfil neither of the above criteria then you are NOT eligible to requisition a resolution. PLEASE NOTE: if your GSK shares are not registered in your own name or you hold GSK ADRs then you should refer to page 9 which explains how you should proceed.

Requisitioning a resolution Eligibility: indirect investors Are you part of a group of 100 or more persons holding £10,000 in nominal value of GSK Ordinary Shares i.e. 40,000 GSK Ordinary Shares or the equivalent thereof in ADRs? If the answer is ‘Yes’ then you should be eligible to requisition a resolution, although certain procedural formalities may be required. If the answer is ‘No’ then you are NOT eligible to requisition a resolution. PLEASE NOTE: if you hold GSK ADRs then you should refer to pages 10 & 11 which explains how you should proceed. If your GSK shares are not registered in your own name then you should refer to page 12.

Requisitioning a resolution Procedure: ADR holders with BNY Mellon ADR holders who hold their ADRs directly with GSK’s ADR Depositary, BNYM, may submit a requisition through BNYM provided that the requisition is: submitted by at least 100 persons with an average of £100 of paid up share capital each and authenticated by all the persons making it; and accompanied by a statement from BNYM or the underlying ADR holder(s) making the request setting out the basis on which ADRs are being held by them/for them. PLEASE NOTE: any costs associated with implementing these arrangements will not be met by GSK.

Requisitioning a resolution Procedure: ADR holders via a broker, nominee or institution ADR holders who do not hold their ADRs via BNYM may submit a requisition provided that it is: submitted by at least 100 persons with an average of £100 of paid up capital each and authenticated by all the persons making it; and accompanied by a statement from the relevant broker, nominee or other institution through which the ADRs are held, or the underlying ADR holder(s) making the request, setting out the basis on which ADRs are being held by them/for them. PLEASE NOTE: any costs associated with implementing these arrangements will not be met by GSK.

Requisitioning a resolution Procedure: Ordinary Shareholders via a nominee Indirect investors holding GSK Ordinary shares via a nominee may submit a requisition provided that the requisition is: submitted by at least 100 persons with an average of £100 of paid up share capital each and authenticated by all the persons making it; and accompanied by a statement from the nominee or underlying shareholder(s) making the request setting out the basis on which the GSK shares are being held by them/for them. More details about this statement are set out on pages 15 to 17. PLEASE NOTE: any costs associated with implementing these arrangements will not be met by GSK.

Requisitioning a resolution Drafting and submission Requisitionists are strongly recommended to seek independent legal advice on the drafting of their requisition Please note that GSK will not meet the requisitionists’ legal or other costs in preparing a requisition.

Requisitioning a resolution Drafting and submission (cont.) Points to note: The requisition should be in English and in a readable form It may be in hard copy or electronic form The resolution being proposed should be capable of being put to a general meeting and should not be defamatory, frivolous or vexatious Where it is being submitted by members the requisition should be signed by all the persons making it, specifying for each member their full name, registered address, account number and the number of GSK Ordinary shares they hold Where a requisition is being submitted by an ADR holder(s) the requisition should be accompanied by a statement setting out the name and address of the registered holder(s), the number of shares/ADRs held and the basis on which the shares/ADRs are being held.

Requisitioning a resolution Supporting Statements Where a requisition for a resolution is being supported by indirect investors as part of the 100 persons requirement (as set out on pages 9 and 12) the requisition must be signed by all the persons making it and be accompanied by a statement for each indirect investor which includes the following: the name and address of the registered member who holds the shares on their behalf; confirmation that the member is holding those shares on their behalf in the course of business; details of the number of shares held on their behalf and the total amount paid up on those shares; confirmation that those shares are not held by the member on behalf of anyone else or, if they are, that such other persons are not involved in the requisition; confirmation that at least some of the shares confer voting rights; and confirmation that they have the right to instruct the member on how to exercise those voting rights.

Requisitioning a resolution Supporting Statements (cont.) If any of the 100 persons is a member, the requisition must also be accompanied by a statement for each such member specifying that they hold shares otherwise than on behalf of another person or that they hold shares on behalf of one or more other persons but those persons are not involved in the requisition This statement should also specify for each member the total amount paid up on the shares held as mentioned in the previous sentence. GSK may also require that the supporting statements are accompanied with such evidence of the above matters which it may reasonably require.

Requisitioning a resolution Supporting Statements (cont.) These requirements also apply where indirect investors support a 100 persons requisition for the circulation of an explanatory statement (see immediately below) The proposed resolution may be accompanied by an explanatory statement of not more than 1,000 (one thousand) words, which should also be signed by each of the requisitionists The resolution, and where supplied an accompanying statement, will be issued on behalf of the requisitionists without giving their names A specific request should be made for each requisitionist’s name to be published When complying with such a request, space constraints may require that a full list of these names be set out in an appendix to the Notice of Meeting.

Requisitioning a resolution Costs UK law specifies that the burden of a company’s costs in complying with a requisition falls on the requisitionists unless a requisition is validly received before the end of the financial year preceding the AGM (31 December). GSK has extended this deadline to 31 January. Therefore, unless a requisition is validly received by this date, the requisitionists are required by law to deposit with GSK a sum reasonably sufficient to meet GSK’s expenses in giving effect to a requisition It is estimated that the cost of requisitioning a resolution could be as high as £200,000. The actual costs of processing a requisition and accordingly the deposit required would be established at the time of receipt of a requisition Requisitionists are entitled to include as part of their requisition a supplementary resolution for shareholders to authorise GSK to meet the costs of complying with the requisition. GSK would reimburse the amount deposited if the supplementary resolution is approved.

Requisitioning a resolution Costs (cont.) GSK will meet its costs in complying with a requisition provided that a valid request is received by 31 January Requisitionists who lodge their requisition after that date will be required to deposit with the company sufficient funds to cover the costs in complying with the requisition and should consider including a supplementary resolution seeking approval for GSK to meet its own costs in complying with the requisition If any supplementary resolution is passed allowing GSK to meet its own costs in complying with the requisition, GSK will refund the deposit within 10 working days of the AGM. Please note that requisitionists will in any event have to meet their own costs in putting forward the requisition. PLEASE NOTE: requisitionists may submit a supplementary resolution to seek approval for GSK to meet its costs in complying with the requisition.

Key dates, contacts and glossary of terms Supplementary Information Key dates, contacts and glossary of terms

Supplementary Information Key dates for GSK’s 2018 AGM Action Date Recommended submission date for member(s)/ADR holders wishing to requisition a resolution 31 January Annual Report and AGM materials to be issued March 2018 UK legal deadline for member(s)/ADR holders wishing to requisition a resolution 20 March 2018 2018 Annual General Meeting 3 May 2018 PLEASE NOTE: These dates may be subject to change which will be posted on the website

Supplementary Information Contacts If you wish to discuss any of these requirements then please contact: Victoria Whyte Company Secretary GlaxoSmithKline plc 980 Great West Road Brentford Middlesex TW8 9GS Tel: +44 (0)20 8047 5000

Supplementary Information Glossary of Terms Requisition: a formal request to a company from one or more of its members or indirect investors to put a resolution to an AGM. Resolution: a proposal for members of a company to consider and decide upon. ADR: an American Depositary Receipt representing two GSK Ordinary shares also referred to as an American Depositary Share. BNYM: BNY Mellon Depositary Receipts, GSK’s depositary bank which holds ADRs on behalf of investors. Member: a shareholder whose name appears on the Register of Members, maintained by GSK’s Registrar, Equiniti. Indirect investor: a person on whose behalf a member holds GSK Ordinary Shares.